Archived Webcast

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Release Date

June 6, 2022

Expiration Date

July 29, 2022

Credits

2.0 CME

Specialties

Oncology

Release Date: June 6, 2022

Expiration Date: July 28, 2022

Activity Overview

This educational activity is an archive of the live virtual presentation held on June 5, 2022.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward oncologists, nurses, and other oncology healthcare professionals involved in the treatment and management of cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain disparities in cancer outcomes and care among diverse patient populations
  • Evaluate strategies to broaden oncology clinical trial opportunities and enrollment among diverse populations
  • Analyze gaps in the screening, diagnosis, treatment selection, and access to care in diverse populations with cancer
  • Identify strategies to overcome disparities in diagnosis, testing, and treatment for patients with cancer
Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Eisai Inc., Genentech, a member of the Roche Group, Gilead Sciences, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, and Sanofi Genzyme.

Course

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Create Account